The ROS-generating photosensitizer-free NaYF₄:Yb,Tm@SiO₂upconverting nanoparticles for photodynamic therapy...

Area of Science:

• Materials Science
• Nanotechnology
• Biomedical Engineering

Background:

• Rare-earth-ion-doped NaYF4 nanoparticles offer unique optical properties for biomedical applications.
• Silicon oxide shells provide biocompatibility and functionalization capabilities.
• Targeted cancer therapy requires efficient methods for selective cell destruction with minimal off-target effects.

Purpose of the Study:

• To adapt NaYF4:20%Yb,0.2%Tm@SiO2 nanoparticles for biological and medical applications, specifically cancer cell imaging and therapy.
• To investigate the potential of these nanoparticles for photosensitizer-free photodynamic therapy (PDT) of cancer cells.
• To demonstrate the feasibility of targeted cancer cell destruction using bio-functionalized nanoparticles.

Main Methods:

• Synthesis of NaYF4:20%Yb,0.2%Tm@SiO2 nanoparticles.
• In vitro photodynamic therapy (PDT) using 4T1 cancer cells and near-infrared (NIR) irradiation.
• Bio-conjugation of anti-human IgG antibodies to the nanoparticle surface.
• Evaluation of targeted cancer cell damage using optical methods.

Main Results:

• NaYF4:20%Yb,0.2%Tm@SiO2 nanoparticles effectively generated reactive oxygen species (ROS) upon NIR excitation for PDT.
• In vitro PDT on 4T1 cells resulted in decreased cell viability below 10% after 24 hours.
• Successful bio-conjugation of antibodies enabled selective targeting and damage of cancer cells.

Conclusions:

• NaYF4:20%Yb,0.2%Tm@SiO2 nanoparticles are effective for photosensitizer-free photodynamic therapy.
• Surface modification allows for targeted delivery and destruction of cancer cells.
• These nanoparticles hold significant potential for advanced targeted cancer therapy.